InsidersTradesSigma
ノイルイミューン・バイオテック株式会社: insider trades · Japan · EDINET (Japan FSA)
EDINET:company-5d1a20JP·EDINET (Japan FSA)Mcap 6944.5Bn€
Discover the full management transaction log of ノイルイミューン・バイオテック株式会社, a listed issuer based in Japan. Shares are quoted on JP JP, under the oversight of EDINET (Japan FSA). Market capitalisation: €6,944.5bn. The latest transaction was disclosed on 5 July 2023 — Holding update. Among the most active insiders: Takeda Pharmaceutical Company, Limited. Every trade is free.
5
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
5249.00 €
Income statement
Revenue4581.55 Bn€
Gross profit3001.33 Bn€66% margin
Net income107.93 Bn€2.4% margin
Balance sheet & cash
Market cap6944.52 Bn€
Total debt4515.27 Bn€
Free Cash Flow677.56 Bn€
Last declaration on 5 July 2023
Declarations5 total
Executives●Holding update10EDINET
€6m0.0001% mcap100.0% of flow
ShareXTKS
EDINET:S100RC2H·
Executives●Holding update10EDINET
€34,4980.0000% mcap100.0% of flow
ShareXTKS
EDINET:S100RC1V·
Executives●Holding update10EDINET
€65,9370.0000% mcap100.0% of flow
ShareXTKS
EDINET:S100RC1P·
Executives●Holding update10EDINET
€27,2280.0000% mcap100.0% of flow
ShareXTKS
EDINET:S100R0PC·
Executives●Holding update10EDINET
€3m0.0000% mcap100.0% of flow
ShareXTKS
EDINET:S100R6G9·
5 of 5 declarations